Affymax Company Insiders
| AFFY Stock | USD 0 0.0006 75.00% |
Affymax employs about 2 people. The company is managed by 3 executives with a total tenure of roughly 23 years, averaging almost 7.0 years of service per executive, having 0.67 employees per reported executive. Break down of Affymax's management performance can provide insight into the company performance.
| Jonathan Couchman CEO President CEO, Director |
Affymax |
Affymax Management Team Effectiveness
The company has return on total asset (ROA) of (2.2891) % which means that it has lost $2.2891 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 1.1159 %, meaning that it created $1.1159 on every $100 dollars invested by stockholders. Affymax's management efficiency ratios could be used to measure how well Affymax manages its routine affairs as well as how well it operates its assets and liabilities.Affymax Workforce Comparison
Affymax is number one stock in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 473. Affymax adds roughly 2.0 in number of employees claiming only tiny portion of equities under Health Care industry.
The company has Profit Margin (PM) of 73.0 %, which can signify that it executes well on its competitive strategies and has good control over its expenditures. This is very large. Affymax Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Affymax Price Series Summation is a cross summation of Affymax price series and its benchmark/peer.
Affymax Notable Stakeholders
An Affymax stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Affymax often face trade-offs trying to please all of them. Affymax's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Affymax's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Jonathan Couchman | President CEO, Director | Profile | |
| Mark Thompson | CFO and Secretary | Profile | |
| JD Dunn | VP Affairs | Profile |
About Affymax Management Performance
The success or failure of an entity such as Affymax often depends on how effective the management is. Affymax management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Affymax management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Affymax management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Previously, it was developing drugs to enhance the treatment of serious and often life-threatening conditions in the United States. The company was founded in 2001 and is based in New York, New York. Affymax operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 2 people.
Please note, the imprecision that can be found in Affymax's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Affymax. Check Affymax's Beneish M Score to see the likelihood of Affymax's management manipulating its earnings.
Affymax Workforce Analysis
Traditionally, organizations such as Affymax use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Affymax within its industry.Affymax Manpower Efficiency
Return on Affymax Manpower
| Revenue Per Employee | 684.5K | |
| Revenue Per Executive | 456.3K | |
| Net Loss Per Employee | 7.2M | |
| Net Loss Per Executive | 4.8M |
Additional Tools for Affymax Pink Sheet Analysis
When running Affymax's price analysis, check to measure Affymax's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Affymax is operating at the current time. Most of Affymax's value examination focuses on studying past and present price action to predict the probability of Affymax's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Affymax's price. Additionally, you may evaluate how the addition of Affymax to your portfolios can decrease your overall portfolio volatility.